Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Time Well Spent: Clinical Predictors of Days Alive and Out of the Hospital After Heart Transplantation
Elissa Driggin1, Carolina Lemos1, Shruti Bidani1
1Center for Advanced Cardiac Care, Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.
Insights
Older age, kidney disease, and longer hospital stays predict fewer days alive and out of the hospital after heart transplantation (HT). These factors are crucial for improving patient outcomes post-transplant.
Area of Science:
- Cardiology
- Transplantation Medicine
- Health Services Research
Background:
- Days Alive and Out of Hospital (DAOH) is a patient-centered outcome gaining traction in heart failure research.
- DAOH has not been extensively studied in the context of heart transplantation (HT).
- Understanding DAOH predictors is vital for improving post-transplant care.
Purpose of the Study:
- To identify predictors of 1-year DAOH after heart transplantation.
- To analyze DAOH in a diverse patient population at a high-volume transplant center.
Main Methods:
- Retrospective analysis of 1141 adult HT recipients (2005-2022).
- Collected baseline demographics and psychosocial factors (insurance, education, language, SES).
- Primary outcome: DAOH at 1 year, accounting for readmissions and rehabilitation stays.
Main Results:
- Mean DAOH was 306 days; 6.3% died during index hospitalization.
- 56% of discharged patients were readmitted within the first year.
- Older age, chronic kidney disease, post-2018 allocation changes, and longer index hospitalization predicted fewer DAOH.
Conclusions:
- DAOH is a valuable metric for assessing health-related quality of life post-HT.
- Integrating patient-centered outcomes like DAOH is essential for the transplant community.
Background:
Days alive and out of the hospital (DAOH) is an increasingly used patient-centered outcome in studies of patients with heart failure, but has not been well studied in heart transplantation (HT). We sought to examine predictors of DAOH at 1-year post-discharge from HT in a diverse population at a large volume HT center.
Methods:
Adult recipients who underwent HT between January 1, 2005 and December 31, 2022 at our institution were included. Baseline demographics were collected as well as psychosocial factors including primary insurance, education, primary language, and socioeconomic status (SES) index as determined by the American Community Survey using patient zip code data. The primary outcome was DAOH at 1 year from HT, accounting for hospital readmissions and time spent in rehabilitation facilities. For patients who died on index admission, DAOH was considered 0.
Results:
A total of 1141 patients (26% female, 16% Hispanic, 24% Black) were included in the primary analysis. Seventy-two patients (6.3%) died during the index HT hospitalization. Mean DAOH was 306 (± 87) days. Among those who survived to hospital discharge, 56% were readmitted at least once in the first year after HT. After adjustment for clinical and psychosocial variables, older age, chronic kidney disease, post-2018 allocation change, and greater length of stay at the index hospitalization were associated with significantly fewer DAOH.
Conclusions:
The integration of patient-centered metrics such as DAOH should be a continued priority in our transplant community as it may better convey health-related quality of life.
Related Concept Videos
Kidney Transplant I: Introduction
Cardiomyopathy V: Interprofessional Care
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy II: Dilated Cardiomyopathy
Kidney Transplant III: Nursing Management

